Grant of Options

RNS Number : 4478C

BrainJuicer Group PLC

16 January 2015

 

Press Release                                                                                                                16 January 2015

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

Management Share Options

The Company announces that it has today granted 137,040 stock options to each of its three executive directors, John Kearon, James Geddes and Alex Batchelor, in accordance with the terms approved by shareholders at the annual general meeting of the Company held on 12 May 2014.  The share price threshold which must be reached in April 2017 for vesting to occur has been set at £5.051.  

Terms of the options are set out below, full details of the share option plan can be found in the 2014 Notice of AGM on the Company's website at www.brainjuicer.com.

The share options are nil cost and will vest on 30 April 2017, subject to the following performance criteria:

(a) 100% of the share options will vest if undiluted earnings per share in 2016 has grown by at least 25% per year (on an annual compound basis) over that reported in the 2013 Annual Report and Accounts;

(b) 33% of the share options will vest if undiluted earnings per share in 2016 has grown by at least 15% per year (on an annual compound basis) over that reported in the 2013 Annual Report and Accounts;

(c) 0% of the share options will vest if undiluted earnings per share in 2016 has grown by less than 15% per year (on an annual compound basis) over that reported in the 2013 Annual Report and Accounts; and

(d) a proportionate number of share options will vest if undiluted earnings per share in 2016 has grown by between 15% and 25% per year (on an annual compound basis) over that reported in the 2013 Annual Report and Accounts.

Vesting will be further subject to the Company's average share price during the month of April 2017 being above the threshold price set out above (being a price set by the Company's remuneration committee, taking account of the share price at today's date of grant).  

Participants may only exercise vested nil cost share options after a twelve month deferral period as from the vesting date.

The Company plans to grant an additional 60,000 stock options to each executive director in April 2015 on the same terms when it may be able to take advantage of the Enterprise Management Investment scheme.

The Company can be found at www.brainjuicer.com  

- Ends -

For further information, please contact:

BrainJuicer Group PLC      

John Kearon, Chief Executive Officer                                    Tel: [phone]

James Geddes, Chief Financial Officer                                 www.brainjuicer.com

Canaccord Genuity Limited           

Simon Bridges / Henry Fitzgerald-O'Connor                          Tel: [phone]

www.canaccordgenuity.com

 

END

 

 

RDSSFAFWMFISEIF